We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Thalassemia

News List

CRISPR Therapeutics Plans to Treat First Patients for Beta Thalassemia in Europe biospace
April 17, 2018
CRISPR Therapeutics is all ready to begin treating patients in Europe using its CRISPR gene-editing tool.
Australian University research gives hope to thalassemia patients biospectrumasia
April 08, 2018
Genome editing or gene editing give scientists the ability to change an organism's DNA
Cerus Reports Positive Top-Line Results from Chronic Anemia Phase 3 Study Evaluating INTERCEPT Red B biospace
January 25, 2018
Cerus Corporation (today reported that the company successfully achieved its primary efficacy and safety endpoint in the Phase III transfusion study of chronic anemia